YungShin Global Holding Corporation (TPE:3705)

Market Cap	14.78B +2.6%
Revenue (ttm)	8.38B +4.3%
Net Income	880.82M -24.6%
EPS	3.31 -24.5%
Shares Out	266.36M
PE Ratio	16.77
Forward PE	n/a
Dividend	3.00 (5.41%)
Ex-Dividend Date	Jun 24, 2026

Volume	363,040
Average Volume	302,006
Open	54.50
Previous Close	54.50
Day's Range	54.50 - 55.70
52-Week Range	51.90 - 69.90
Beta	0.06
RSI	61.17
Earnings Date	May 12, 2026

About YungShin Global Holding

YungShin Global Holding Corporation, through its subsidiaries, invests in, manufactures, and sells medicines, animal drugs, agricultural chemicals, industrial medicines, and cosmetics. It is also involved in the sale of medicine; trade, investment, and other related businesses; import and export trading; and food manufacturing. The company operates in Taiwan, the United States, Mainland China, and Japan. YungShin Global Holding Corporation was founded in 1952 and is based in Taipei, Taiwan.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1952
• Country: Taiwan
• Stock Exchange: Taiwan Stock Exchange
• Ticker Symbol: 3705

Financial Performance

In 2025, YungShin Global Holding's revenue was 8.38 billion, an increase of 4.28% compared to the previous year's 8.03 billion. Earnings were 880.82 million, a decrease of -24.62%.